Bolamin
Bolamin is a Khavinson short peptide bioregulator for the bone marrow. Proposed to support hematopoiesis and bone marrow stem cell function in aging. Used in anti-aging research targeting immune aging and hematopoietic reserve.
⚠ Research & Educational Use Only. Bolamin is a research chemical documented here for scientific education. All information references peer-reviewed literature and preclinical/clinical study data. Not for human consumption. Not medical advice. Consult a licensed researcher or healthcare professional before any laboratory use.
- Proposed to support hematopoietic stem cell gene expression and bone marrow function in aging
- May complement thymic bioregulators (Thymalin, Thymagen) by addressing the bone marrow side of immune aging
- Part of comprehensive anti-aging protocols targeting the hematopoietic-immune axis
- Bolamin is not FDA-approved for human use. It is a research chemical for scientific study only.
Research At a Glance
- Proposed to support hematopoietic stem cell gene expression and bone marrow function in aging
- May complement thymic bioregulators (Thymalin, Thymagen) by addressing the bone marrow side of immune aging
- Part of comprehensive anti-aging protocols targeting the hematopoietic-immune axis
- Bone marrow bioregulation is proposed to support red blood cell production capacity in aging
What is Bolamin?
Bolamin is a peptide bioregulator developed by Professor Khavinson's St. Petersburg Institute of Bioregulation and Gerontology, derived from bone marrow tissue. It is designed to target hematopoietic aging — the age-related decline in bone marrow stem cell number, function, and output.
In the Khavinson bioregulator framework, each organ has a corresponding short regulatory peptide that can help maintain or restore youthful gene expression patterns in that organ's cells. Bolamin represents the bone marrow/hematopoietic tissue in this system, complementing thymic preparations (Thymalin, Thymagen) which target T-lymphocyte development in the thymus.
The bone marrow and thymus together constitute the primary lymphoid organs — where lymphocytes are born (marrow) and educated (thymus). Aging is associated with
- Reduced hematopoietic stem cell (HSC) self-renewal capacity
- Shift from lymphopoiesis toward myelopoiesis in aging HSCs (which may contribute to immune aging)
- Reduced erythropoietic reserve
- Declining immune reconstitution capacity
Bolamin is proposed to address the marrow side of this equation. It is often used in comprehensive anti-aging protocols alongside Thymalin (thymus), Epithalon (pineal), Cartalax (cartilage), and Vesugen (vascular) as part of the multi-organ bioregulator approach.
Key Research Benefits
Documented effects observed in preclinical and clinical studies on Bolamin. See all Muscle & Performance peptides for comparison.
Side Effects & Risks
Adverse effects reported in the research literature. All data sourced from preclinical and clinical study reports.
Dosing Data from the Literature
Doses referenced below are sourced from published preclinical and clinical studies. Use the peptide dose calculator to convert these values to injection volume.
Administration in Research Settings
Standard reconstitution and administration methodology for laboratory research use.
Oral capsule. Part of the Khavinson Institute organ-targeted bioregulator system.
Explore Further
Quick Reference
Research Use Only
This information is for educational research purposes only. This is not medical advice. Consult a qualified healthcare professional.